Bot Detector
LEARN MORE
A subscription to
IJPC
provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
LEARN MORE
Sign On
The Journal
Editor-In-Chief
Editorial Calendar
Submissions
Advertising
Permissions & Reprints
Privacy Policy
Contact Us
Subscribe
Renew
Prices
Free Sample
View Cart
Articles
Issues
Archives
Supplemental Content and Errata
Training and Education
IJPC-PCAB SOP Matrix
USP GAP Analysis
Compounders' Network List
Patient Information
Videos
Compounders' Resource Directory
Mar/Apr 2025 - Volume 29, Number 2
Purchase the entire back issue in electronic PDF or print format.
(Select Format)
PDF — $95
Purchase or view individual articles by selecting the article in the table below...
Individual Articles - Mar/Apr 2025 - Volume 29, Number 2
Title/Author
(Click for Abstract / Details / Purchase)
Issue/Page
View/Buy
Prescription - The Architecture of Compounding: Building a Stronger Future
Kupiec Thomas C
Mar/Apr 2025
Pg. 90
Let’s Talk About Outside Sales Reps for Compounding Pharmacies
Roberts Jerrod
Mar/Apr 2025
Pg. 92-94
Current Problems of Pharmaceutical Compounding in Hungary
Dobson Szabolcs
Mar/Apr 2025
Pg. 96-103
Advertising and Marketing for Compounding Pharmacies: Many Shades of Grey
Hobbs Amanda F
,
Howard Brad
Mar/Apr 2025
Pg. 104-110
Book Review of The Chapter <795> Answer Book 2nd Edition
Fredrickson Mary E
,
Schreffler Rebecca
Mar/Apr 2025
Pg. 112-115
New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins
Ashworth Lisa D
Mar/Apr 2025
Pg. 116-119
Calculations - Potassium Phosphate and Sodium Phosphate Oral Tablets
Stockton Shelly J
Mar/Apr 2025
Pg. 120
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Mar/Apr 2025
Pg. 121
Atropine Sulfate 1% Ophthalmic Solution
Mar/Apr 2025
Pg. 122
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Gel
Mar/Apr 2025
Pg. 123-124
Chlorothiazide 50-mg/mL Oral Suspension
Mar/Apr 2025
Pg. 125
Folic Acid 1-mg/mL Oral Liquid
Mar/Apr 2025
Pg. 126
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide-Magnesium Hydroxide-Simethicone Mouthwashes
Mar/Apr 2025
Pg. 127
Tetracaine Hydrochloride 2% Topical Solution
Mar/Apr 2025
Pg. 128
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Mar/Apr 2025
Pg. 129
Topiramate 6-mg/mL Oral Suspension
Mar/Apr 2025
Pg. 130
Vancomycin 31-mg/mL Ophthalmic Solution
Mar/Apr 2025
Pg. 131
Formulation and Characterization of Ophthalmic in Situ Gel Forming Solution of Timolol Maleate for Glaucoma
Rajagopal Kumaravelrajan
,
Kanmani Gokul
,
Venkatesan Suba
,
Palanivelu Amudha
Mar/Apr 2025
Pg. 132-140
Long-term Physicochemical Stability of a Pharmaceutical Preparation of Morphine Hydrochloride and Droperidol in Polypropylene Syringes
Nobels Amandine
,
Closset Mélanie
,
Bihin B
,
Jamart Jacques
,
Soumoy Laura
,
Lombet Louise
,
Hecq Jean-Daniel
,
Galanti Laurence
,
Colsoul Marie-Lise
,
Catry Emilie
Mar/Apr 2025
Pg. 141-149
Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm™, a Cream Base for Personalized Dermatological Treatments
Marianni Bruna
,
Silva Carolina Costa Vicente
,
Polonini Hudson
Mar/Apr 2025
Pg. 150-162
Assessing the Compatibility of Different Formulations in OrPhyllo™, A Ready-to-Use Base for Personalized Orodispersible Films
Marianni Bruna
,
Polonini Hudson
,
Koulouridas Savvas
Mar/Apr 2025
Pg. 163-175
Return to Top